Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

✍ Scribed by E. Garcia-Giralt; Y. Ayme; M. Carton; A. Daban; T. Delozier; P. Fargeot; P. Fumoleau; A. Gorins; D. Guerin; R. Guerin; P. Maillart; L. Mauriac; F. May-Levin; R. Metz; M. Namer; J. P. Olivier; E. Pommatau; P. Pouillart; E. Pujade-Lauraine; J. Rouesse; B. Serrou; M. Vitse; D. Zylberait

• Publisher: Springer US
• Year: 1992
• Tongue: English
• Weight: 602 KB
• Volume: 24
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/bf01961246